Abstract:Background: Accumulating evidence indicates that aberrant activation of the Hedgehog (Hh) signalling pathway by Glioma-associated oncogene (Gli) transcription factors is involved in the aggressive progression of cancers, including ovarian cancer. Whereas the molecular mechanism underlying this phenomenon remains unelucidated. Matrix metalloproteinase-7 (MMP-7) facilitates degradation of the extracellular matrix, promoting the invasion of tumour cells, and is associated with cancer progression and metastasis. In previous reports, we identified a set of genes regulated by Hh signalling in ovarian tumour cells among which MMP-7 was identified as a potential Hh target gene candidate. However, establishing an association between Hh signalling activation and MMP-7 expression requires further validation, and the function of this regulation remains unknown. Methods: A cDNA microarray was utilized to identify potential downstream targets of Hh signalling. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to evaluate mRNA expression, and immunoblotting (IB) was conducted to evaluate protein expression. The invasive and migratory capabilities of tumour cells were tested with the transwell and wound healing assays, respectively. The mRNA levels of Gli2 and MMP-7 in normal ovarian tissues and cancerous tissues in various stages together with the corresponding clinical information were acquired from the indicated GEO datasets to elucidate associations between MMP-7 expression and cancer progression and prognosis. Additionally, immunohistochemistry (IHC) was performed in multiple ovarian cancers, benign tumours and normal tissues to evaluate Gli2 and MMP-7 protein expression. Results: MMP-7 expression was regulated by the Hh ligand, antagonist and downstream transcript factor Gli2, demonstrating this gene as an Hh target. MMP-7 facilitated the invasion and migration of ovarian tumour cells, indicating its key function in ovarian cancer progression. IHC analysis demonstrated abnormally increased Gli2 and MMP-7 expression levels in benign tumours and ovarian cancer tissues. Moreover, high MMP-7 levels were significantly associated with poor overall survival (OS) and poor progression-free survival (PFS) in ovarian cancer patients. Conclusion: Aberrant activation of the Hh-Gli-MMP-7 signalling axis is essential for acceleration of the progression and metastasis of human ovarian cancer, implicating its use as a novel therapeutic target of ovarian cancer. In addition, MMP-7 can potentially serve as a prognostic marker of ovarian cancer.

HDAC7 promotes ovarian cancer malignancy via AKT/mTOR signalling pathway

HDAC9 Contributes to Serous Ovarian Cancer Progression Through Regulating Epithelial–Mesenchymal Transition

Platelet-activating Factor Acetyl Hydrolase IB2 Dysregulated Cell Proliferation in Ovarian Cancer

Silencing HDAC1 Expression Regulates Extracellular Regulated Protein Kinases/Mitogen-Activated Protein Kinase Signaling Activation and Enhances Chemosensitivity of Ovarian Carcinoma

Knockdown of Hypoxia-Inducible Factor 1α (Hif-1Α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (pi3k)/akt/mammalian Target of Rapamycin (mtor) Signaling Pathway in Ovarian Cancer Cells

The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis

HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN/AKT/mTOR pathway

Aberrant Activation Of Hedgehog Signalling Promotes Cell Migration And Invasion Via Matrix Metalloproteinase-7 In Ovarian Cancer Cells.

HDACs Alters Negatively to the Tumor Immune Microenvironment in Gynecologic Cancers.

Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation

HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway

Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter

Knockdown of EHF inhibited the proliferation, invasion and tumorigenesis of ovarian cancer cells

Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.

HDAC7: a promising target in cancer

OCT4 induces EMT and promotes ovarian cancer progression by regulating the PI3K/AKT/mTOR pathway

KAT6A, a Novel Regulator of Β-Catenin, Promotes Tumorigenicity and Chemoresistance in Ovarian Cancer by Acetylating COP1

PAX8 Regulon in Human Ovarian Cancer Links Lineage Dependency with Epigenetic Vulnerability to HDAC Inhibitors.

Small Ribosomal Protein Subunit S7 Suppresses Ovarian Tumorigenesis Through Regulation of the Pi3k/Akt and Mapk Pathways

Adenylate Kinase 7 is a Prognostic Indicator of Overall Survival in Ovarian Cancer.

HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3